|

CAPOX 6 month Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2/3: 1

Top Sponsors

  • NRG Oncology1

Indications

  • Stage III Colon Cancer1
  • Cancer1

Birmingham, Alabama1 trial

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

University of Alabama at Birmingham Cancer Center

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.